Kosalaram Goteti

7PUBLICATIONS
36CO-AUTHORS
Pharmaceutical delivery technologiesPharmacogenomicsDevelopment cooperationBiomolecular modelling and designCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Oct 24, 2024
Asia-inclusive drug development leveraging principles of ICH E5 and E17 guidelines: Case studies illustrating quantitative clinical pharmacology as a foundational enabler.

Hong Lu, Lena Klopp-Schulze, Jatinder Kaur Mukker

|Jul 08, 2024
Role of Clinical Pharmacology in Diversity and Inclusion in Global Drug Development: Current Practices and Industry Perspectives: White Paper.

Aarti Sawant-Basak, Shweta Urva, Jatinder Kaur Mukker

|Feb 28, 2024
Asia-Inclusive Global Development of Enpatoran: Results of an Ethno-Bridging Study, Intrinsic/Extrinsic Factor Assessments and Disease Trajectory Modeling to Inform Design of a Phase II Multiregional Clinical Trial.

Lena Klopp-Schulze, Sathej Gopalakrishnan, Özkan Yalkinoglu

|Dec 05, 2023
Model-based meta-analysis using latent variable modeling to set benchmarks for new treatments of systemic lupus erythematosus.

Kosalaram Goteti, Ramon Garcia, William R Gillespie

|Oct 01, 2023
Model-Informed Selection of the Recommended Phase III Dose of the Inhibitor of Apoptosis Protein Inhibitor, Xevinapant, in Combination with Cisplatin and Concurrent Radiotherapy in Patients with Locally Advanced Squamous Cell Carcinoma of the Head and Neck.

Yulia Vugmeyster, Abhigyan Ravula, Elisabeth Rouits

|Feb 21, 2023
Opportunities and Challenges of Disease Progression Modeling in Drug Development - An IQ Perspective.

Kosalaram Goteti, Nathan Hanan, Mindy Magee

Pageof 2

Frequent Collaborators

5 joint publications

Karthik Venkatakrishnan

2 joint publications

Jonathan French

2 joint publications

Jatinder Kaur Mukker

2 joint publications

Lena Klopp-Schulze